Literature DB >> 17143605

Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION Study, Denmark.

S S Rasmussen1, C Glümer, A Sandbaek, T Lauritzen, K Borch-Johnsen.   

Abstract

AIMS/HYPOTHESIS: To estimate the 1-year progression rates from both IFG and IGT to diabetes in individuals identified in a pragmatic diabetes screening programme in general practice (the ADDITION Study, Denmark [Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care]).
METHODS: Persons aged 40-69 years were screened for type 2 diabetes based on a high-risk, stepwise strategy. At baseline, anthropometric measurements, blood samples and questionnaire data were collected. A total of 1,160 persons had IFG or IGT at baseline: 811 (70%) accepted re-examination after 1 year. Glucose tolerance classification was based on the 1999 WHO definition. At follow-up, diabetes was based on one diabetic glucose value of fasting blood glucose or 2-h blood glucose.
RESULTS: At baseline, 308 persons had IFG and 503 had IGT. The incidence of diabetes was 17.6 and 18.8 per 100 person-years in the two groups, respectively. CONCLUSIONS/
INTERPRETATION: IFG and IGT identified in general practice during a stepwise, high-risk screening programme for type 2 diabetes have high 1-year progression rates to diabetes. Consequently, intensive follow-up and intervention strategies are recommended for these high-risk individuals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143605     DOI: 10.1007/s00125-006-0530-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

1.  Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms.

Authors:  J O Christensen; A Sandbaek; T Lauritzen; K Borch-Johnsen
Journal:  Diabetologia       Date:  2004-09-08       Impact factor: 10.122

Review 2.  Screening for Type 2 diabetes--should it be now?

Authors:  K Borch-Johnsen; T Lauritzen; C Glümer; A Sandbaek
Journal:  Diabet Med       Date:  2003-03       Impact factor: 4.359

3.  Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.

Authors:  F de Vegt; J M Dekker; A Jager; E Hienkens; P J Kostense; C D Stehouwer; G Nijpels; L M Bouter; R J Heine
Journal:  JAMA       Date:  2001-04-25       Impact factor: 56.272

4.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

5.  Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis.

Authors:  O Vaccaro; G Ruffa; G Imperatore; V Iovino; A A Rivellese; G Riccardi
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

6.  Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.

Authors:  Kinori Kosaka; Mitsuihiko Noda; Takeshi Kuzuya
Journal:  Diabetes Res Clin Pract       Date:  2005-02       Impact factor: 5.602

7.  Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia.

Authors:  Q Qiao; J Lindström; T T Valle; J Tuomilehto
Journal:  Diabet Med       Date:  2003-12       Impact factor: 4.359

8.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

9.  The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study.

Authors:  F de Vegt; J M Dekker; C D Stehouwer; G Nijpels; L M Bouter; R J Heine
Journal:  Diabetes Care       Date:  1998-10       Impact factor: 19.112

10.  A Danish diabetes risk score for targeted screening: the Inter99 study.

Authors:  Charlotte Glümer; Bendix Carstensen; Annelli Sandbaek; Torsten Lauritzen; Torben Jørgensen; Knut Borch-Johnsen
Journal:  Diabetes Care       Date:  2004-03       Impact factor: 19.112

View more
  14 in total

1.  [Screening and prevention of diabetes].

Authors:  P E H Schwarz
Journal:  Internist (Berl)       Date:  2015-10       Impact factor: 0.743

2.  Risk factors for impaired glucose tolerance in obese children and adolescents.

Authors:  Michaela Kleber; Gideon de Sousa; Sophie Papcke; Thomas Reinehr
Journal:  World J Diabetes       Date:  2010-09-15

3.  General effect on high-risk persons when general practitioners are trained in intensive treatment of type 2 diabetes.

Authors:  Signe S Rasmussen; Charlotte Glümer; Annelli Sandbaek; Torsten Lauritzen; Knut Borch-Johnsen
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

Review 4.  Metabolic Syndrome in Children and Adolescents: a Critical Approach Considering the Interaction between Pubertal Stage and Insulin Resistance.

Authors:  Thomas Reinehr
Journal:  Curr Diab Rep       Date:  2016-01       Impact factor: 4.810

5.  Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis.

Authors:  Clare L Gillies; Paul C Lambert; Keith R Abrams; Alex J Sutton; Nicola J Cooper; Ron T Hsu; Melanie J Davies; Kamlesh Khunti
Journal:  BMJ       Date:  2008-04-21

6.  Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark.

Authors:  S S Rasmussen; C Glümer; A Sandbaek; T Lauritzen; K Borch-Johnsen
Journal:  Diabetologia       Date:  2007-12-05       Impact factor: 10.122

7.  Do characteristics of practices and general practitioners influence the yield of diabetes screening in primary care? The ADDITION Netherlands study.

Authors:  Paul G H Janssen; Kees J Gorter; Ronald P Stolk; Guy E H M Rutten
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

8.  Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation.

Authors:  Soroush Mortaz; Christine Wessman; Ross Duncan; Rachel Gray; Alaa Badawi
Journal:  Clinicoecon Outcomes Res       Date:  2012-04-10

9.  Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study.

Authors:  Paul G H Janssen; Kees J Gorter; Ronald P Stolk; Mehmet Akarsubasi; Guy E H M Rutten
Journal:  BMC Fam Pract       Date:  2008-12-16       Impact factor: 2.497

10.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.